Upstream Optimization Paved a Straightforward Path for High Percentage of Full Capsids in AAV6

被引:0
|
作者
Fasano, James [1 ]
Hassaninasab, Azam [1 ]
Kennedy, Daniel [1 ]
Dao, Theresa [1 ]
Cai, Jay [1 ]
Matalka, Omar [1 ]
Beaudry, Christine [1 ]
Williams, Miranda [1 ]
Ponce, Lorenz [1 ]
Spooner, Arianna [1 ]
Sinclair, Emily [1 ]
Yin, Bojiao [1 ]
Segura, Maria Mercedes [1 ]
机构
[1] ElevateBio, Waltham, MA USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
424
引用
收藏
页码:222 / 223
页数:2
相关论文
共 21 条
  • [1] Strategies in AAV Upstream Process and Downstream Purification for High Yield and High Separation of AAV Empty and Full Capsids
    Mallory, Heather
    Liu, Xiaojun
    Jiang, Jun
    Zhu, Jing
    Zhang, Jason
    MOLECULAR THERAPY, 2021, 29 (04) : 400 - 400
  • [2] POROS CaptureSelect AAVX Wash Optimization Study for Optimized Recovery and Purity of AAV6 Capsids
    England, Jeneffer
    Molinari, James
    MOLECULAR THERAPY, 2022, 30 (04) : 537 - 537
  • [3] Characterization of AAV Percentage of Full Capsids and Comparability across Platforms
    Ahern, Rachael Maureen
    Drouin, Lauren M.
    Starremans, Patrick G.
    MOLECULAR THERAPY, 2019, 27 (04) : 348 - 349
  • [4] Optimization of a Scalable Upstream Process for Novel AAV Capsids
    Acharya, Hari
    Adamson, Laura
    Morales, Heidy
    Chu, Dave
    Murphy, Rob
    Springfield, Emily
    Troisi, Elissa
    MOLECULAR THERAPY, 2022, 30 (04) : 536 - 537
  • [5] Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytes
    Rogers, Geoffrey L.
    Huang, Chun
    Clark, Robert D. E.
    Seclen, Eduardo
    Chen, Hsu-Yu
    Cannon, Paula M.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 23 : 198 - 209
  • [6] Optimization of Transfection Reagent Formulation and Experimental Conditions to Maximize the Percentage of Full Adeno-Associated Virus Capsids
    Ludtke, James J.
    Hart, Oksana
    Rossi, Nicolas
    Wang, Yuyuan
    Pinchuk, Anatoly
    Juckem, Laura
    MOLECULAR THERAPY, 2023, 31 (04) : 605 - 605
  • [7] Dual AAV6 Vector Efficiently Delivered Full-Length CFTR Gene and Restored Chanel Function in Primary Human AEC
    Colon-Cortes, Yenerys
    Baumlin-Schmid, Nathalie
    Sharma, Neeraj
    Suk, Jung Soo
    Cutting, Garry
    Salathe, Matthias A.
    Abu Hasan, Mutasim
    Aslanidi, George
    MOLECULAR THERAPY, 2018, 26 (05) : 351 - 351
  • [8] Optimization of the Capsid of Recombinant Adeno-Associated Virus 6 (AAV6) Vectors for Liver-, and Muscle-Directed Gene Therapy
    Nolasco, Diego
    Van Vliet, Kim
    Markusic, David
    Ling, Chen
    Huang, Lin-Ya
    Agbandje-McKenna, Mavis
    Srivastava, Arun
    Aslanidi, George
    MOLECULAR THERAPY, 2015, 23 : S127 - S127
  • [9] Bioprocess Optimization for Improved AAV Titer and Percent Full Capsids with a Sf-Rhabdovirus-Negative Insect Cell Line and CD Insect Cell Medium
    McNorton, Sandra
    MOLECULAR THERAPY, 2024, 32 (04) : 500 - 500
  • [10] High-Efficiency Transduction of Primary Human Hematopoietic Stem/Progenitor Cells by AAV6 Vectors: Strategies for Overcoming Donor-Variation and Implications in Genome Editing
    Ling, Chen
    Bhukhai, Kanit
    Yin, Zifei
    Tan, Mengqun
    Yoder, Mervin C.
    Leboulch, Philippe
    Payen, Emmanuel
    Srivastava, Arun
    SCIENTIFIC REPORTS, 2016, 6